Skip to Main Content

Author Details

Dennis J Hoover
Synaptic Dynamics Inc.
1981
43
26
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
22944582Uranium quantification in semen by inductively coupled plasma mass spectrometry.J Trace Elem Med Biol2013
24215237Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators.J Med Chem2013
23439138The Gulf War depleted uranium cohort at 20 years: bioassay results and novel approaches to fragment surveillance.Health Phys2013
24900408Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.ACS Med Chem Lett2012
21432717Longitudinal health surveillance in a cohort of Gulf War veterans 18 years after first exposure to depleted uranium.J Toxicol Environ Health A2011
18979351Surveillance results of depleted uranium-exposed Gulf War I veterans: sixteen years of follow-up.J Toxicol Environ Health A2009
17194716Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.Drug Metab Dispos2007
17563493Health surveillance of Gulf War I veterans exposed to depleted uranium: updating the cohort.Health Phys2007
16075297Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium.Int Arch Occup Environ Health2006
16537796Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: application to liver glycogen phosphorylase a inhibitors.J Pharmacol Exp Ther2006
15450757Prenatal HgCl2 exposure in BALB/c mice: gender-specific effects on the ontogeny of the immune system.Dev Comp Immunol2005
15604516Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.J Lipid Res2005
14713562Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up.J Toxicol Environ Health A2004
12896845Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus.Environ Health Perspect2003
12204691Structure-activity analysis of the purine binding site of human liver glycogen phosphorylase.Chem Biol2002
11765683Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort.J Occup Environ Med2001
11227044Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.Expert Opin Investig Drugs2001
10662531Health effects of depleted uranium on exposed Gulf War veterans.Environ Res2000
10898591Lead interaction with human protamine (HP2) as a mechanism of male reproductive toxicity.Chem Res Toxicol2000
10940971Lead effects on protamine-DNA binding.Am J Ind Med2000
10980448Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.Chem Biol2000
11061973X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.J Mol Biol2000
9862200A 2.3 A resolution structure of chymosin complexed with a reduced bond inhibitor shows that the active site beta-hairpin flap is rearranged when compared with the native crystal structure.Protein Eng1998
9465093Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.Proc Natl Acad Sci U S A1998
9685232Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.J Med Chem1998
9135120The three-dimensional structure at 2.4 A resolution of glycosylated proteinase A from the lysosome-like vacuole of Saccharomyces cerevisiae.J Mol Biol1997
8540316Discovery of inhibitors of human renin with high oral bioavailability.Adv Exp Med Biol1995
1304340Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.Protein Sci1992
1525154Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes.Biochemistry1992
1472368Rat Sertoli and spermatogenic cells express a similar gene, and its product is antigenically related to an outer dense fiber-associated protein.Mol Reprod Dev1992
1472369Developmental expression of the S35-S45/SGP-2/TRPM-2 gene in rat testis and epididymis.Mol Reprod Dev1992
1954879Androgen metabolism by porcine granulosa cells during the process of luteinization in vitro: identification of 19-oic-androstenedione as a major metabolite and possible precursor for the formation of C18 neutral steroids.Endocrinology1991
1812709Crystal structures of rhizopuspepsin/inhibitor complexes.Adv Exp Med Biol1991
1812716X-ray analysis of a difluorostatone renin inhibitor bound as the tetrahedral hydrate to the aspartic protease endothiapepsin.Adv Exp Med Biol1991
2676515High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.EMBO J1989
6300233Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.J Immunol1983
6411912Changes in inhibin activity, and progesterone, oestrogen and androstenedione concentrations, in rat follicular fluid throughout the oestrous cycle.J Reprod Fertil1983
6221518Biology of the C-6-sulfidopeptide leukotrienes.Adv Prostaglandin Thromboxane Leukot Res1983
6289394The role of nonsteroidal regulators in control of oocyte and follicular maturation.Recent Prog Horm Res1982
6817606Hormonal control of inhibin secretion.Adv Exp Med Biol1982
6296855Radioimmunoassay for leukotriene B4.Proc Natl Acad Sci U S A1982
6796149Inhibitory effects of porcine follicular fluid on monkey serum FSH levels and follicular maturation.Biol Reprod1981
7014598Relationship between human follicular fluid inhibin F activity and steroid content.J Clin Endocrinol Metab1981
  • 1 - 43 of 43

Recommended Authors

National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 2000
Number of shared co-authors 1
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1992
Number of shared co-authors 0
Massey Cancer Center, Virginia Commonwealth University
Career Start Year 1992
Number of shared co-authors 0
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 0
Lilly Research Laboratories
Career Start Year 1990
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 0
Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
University Medical Center Hamburg-Eppendorf
Career Start Year 1989
Number of shared co-authors 0
Lilly Research Laboratories
Career Start Year 1988
Number of shared co-authors 3
Division of Pharmacy and Optometry, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
Vrije Universiteit Amsterdam (VU)
Career Start Year 1987
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 1987
Number of shared co-authors 3
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0
Clinical Trials Group
Career Start Year 1986
Number of shared co-authors 0
Broad Institute
Career Start Year 1985
Number of shared co-authors 0
University of Washington
Career Start Year 1984
Number of shared co-authors 1
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 1
University of Texas Health Science Center at San Antonio Texas78229 USA.
Career Start Year 1973
Number of shared co-authors 0
PHusis Therapeutics Inc.
Career Start Year 1970
Number of shared co-authors 0
University Medical Center Hamburg-Eppendorf
Career Start Year 1969
Number of shared co-authors 0
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 0
ICAR-Central Institute of Fisheries Education
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Heartand Lung Research Institute, University of Cambridge
Co-authored papers 5
University College London
Co-authored papers 5
Pfizer Inc.
Co-authored papers 4
Center for Bioenergy, SASTRA Deemed University
Co-authored papers 3
Brigham & Women's Hospital
Co-authored papers 3
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
Co-authored papers 2
Lilly Research Laboratories
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Hoag Memorial Hospital Presbyterian
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Abo Akademi University
Co-authored papers 1